Brown Trout Management
Latest statistics and disclosures from Chicago Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Horizon Therapeutics, Activision Blizzard, Intercept Pharmaceuticals In, Kaman Corp convertible security, Cheesecake Factory, and represent 68.48% of Chicago Capital Management's stock portfolio.
- Added to shares of these 10 stocks: Activision Blizzard (+$5.1M), Intercept Pharmaceuticals In, Cheesecake Factory, Hersha Hospitality Tr Pr Shs Ben Int, Nisource, AMNB, SABR, Blue Apron Hldgs, stock, Horizon Therapeutics.
- Started 10 new stock positions in stock, UGIC, Nisource, Intercept Pharmaceuticals In, Blue Apron Hldgs, Activision Blizzard, Hersha Hospitality Tr Pr Shs Ben Int, SABR, Cheesecake Factory, AMNB.
- Reduced shares in these 10 stocks: Iveric Bio (-$14M), Life Storage Inc reit (-$13M), Coherent Corp (-$9.8M), Focus Finl Partners (-$8.0M), Sabre Corp, Vectivbio Hldg, Radius Global Infrastrctre I, IRBT, Aes Corp, Kaman Corp convertible security.
- Sold out of its positions in Coherent Corp, Focus Finl Partners, Iveric Bio, Life Storage Inc reit, Radius Global Infrastrctre I, Sabre Corp, Salisbury Ban, Vectivbio Hldg.
- Chicago Capital Management was a net seller of stock by $-40M.
- Chicago Capital Management has $38M in assets under management (AUM), dropping by -51.42%.
- Central Index Key (CIK): 0001580162
Tip: Access up to 7 years of quarterly data
Positions held by Brown Trout Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Chicago Capital Management
Chicago Capital Management holds 18 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Horizon Therapeutics Pub L SHS | 30.3 | $12M | +3% | 81k | 141.69 |
|
| Activision Blizzard | 13.4 | $5.1M | NEW | 86k | 58.97 |
|
| Intercept Pharmaceuticals In | 12.2 | $4.6M | NEW | 186k | 24.82 |
|
| Kaman Corp Note 3.250% 5/0 (Principal) | 6.9 | $2.6M | -11% | 2.6M | 0.99 |
|
| Cheesecake Factory Note 0.375% 6/1 (Principal) | 5.7 | $2.2M | NEW | 2.6M | 0.83 |
|
| iRobot Corporation (IRBT) | 5.4 | $2.0M | -32% | 78k | 26.08 |
|
| Clarivate 5.25% Pfd Conv A (CLVT.PA) | 4.7 | $1.8M | -6% | 61k | 29.23 |
|
| Greenhill & Co | 4.0 | $1.5M | -7% | 104k | 14.68 |
|
| Aes Corp Unit 02/15/2024 | 3.7 | $1.4M | -20% | 23k | 61.00 |
|
| Herbalife Note 2.625% 3/1 (Principal) | 2.7 | $1.0M | +3% | 1.0M | 0.98 |
|
| Hersha Hospitality Tr Pr Shs Ben Int | 2.3 | $878k | NEW | 92k | 9.56 |
|
| Nisource Unit 12/01/2023 | 2.0 | $768k | NEW | 7.9k | 97.45 |
|
| American National BankShares (AMNB) | 1.6 | $612k | NEW | 14k | 42.71 |
|
| Sabre (SABR) | 1.6 | $598k | NEW | 133k | 4.49 |
|
| Rbc Bearings 5% Cnv Pfd Sr A (RBCP) | 1.2 | $457k | -11% | 4.2k | 110.11 |
|
| Blue Apron Hldgs | 1.1 | $401k | NEW | 29k | 13.88 |
|
| stock | 1.0 | $390k | NEW | 13k | 30.26 |
|
| Ugi Corp Unit 06/01/2024 (UGIC) | 0.2 | $58k | NEW | 19k | 3.09 |
|
Past Filings by Chicago Capital Management
SEC 13F filings are viewable for Chicago Capital Management going back to 2015
- Chicago Capital Management 2023 Q3 filed Nov. 14, 2023
- Chicago Capital Management 2023 Q2 filed Aug. 14, 2023
- Chicago Capital Management 2023 Q1 filed May 11, 2023
- Chicago Capital Management 2022 Q4 filed Feb. 14, 2023
- Chicago Capital Management 2022 Q3 filed Nov. 9, 2022
- Chicago Capital Management 2022 Q2 filed July 27, 2022
- Chicago Capital Management 2022 Q1 filed May 11, 2022
- Chicago Capital Management 2021 Q4 filed Jan. 28, 2022
- Chicago Capital Management 2021 Q3 filed Nov. 12, 2021
- Chicago Capital Management 2021 Q2 filed Aug. 11, 2021
- Chicago Capital Management 2021 Q1 filed May 4, 2021
- Chicago Capital Management 2020 Q4 filed Feb. 10, 2021
- Chicago Capital Management 2020 Q3 filed Nov. 6, 2020
- Chicago Capital Management 2020 Q2 filed Aug. 13, 2020
- Chicago Capital Management 2020 Q1 filed May 14, 2020
- Chicago Capital Management 2019 Q4 filed Feb. 12, 2020